Tolerability and toxicity
| Variable, n % . | Grade 1-2 . | Grade 3 . | Grade 4 . | Grade 5 . |
|---|---|---|---|---|
| Neutropenia | 6 (10) | 6 (10) | 35 (56) | — |
| Thrombocytopenia | 21 (34) | 15 (24) | 11 (18) | — |
| Anemia | 47 (76) | 6 (10) | 1 (2) | — |
| Febrile neutropenia | — | 3 (5) | 1 (2)* | — |
| Hepatotoxicity | 7 (11) | 1 (2) | 1 (2) | — |
| Urinary tract infection | — | 1 (2) | — | — |
| Constipation | 1 (2) | — | — | — |
| Cardiotoxicity† | 1 (2)* | — | — | — |
| NGR-hTNF infusion reaction‡ | 1 (2) | — | — | — |
| Variable, n % . | Grade 1-2 . | Grade 3 . | Grade 4 . | Grade 5 . |
|---|---|---|---|---|
| Neutropenia | 6 (10) | 6 (10) | 35 (56) | — |
| Thrombocytopenia | 21 (34) | 15 (24) | 11 (18) | — |
| Anemia | 47 (76) | 6 (10) | 1 (2) | — |
| Febrile neutropenia | — | 3 (5) | 1 (2)* | — |
| Hepatotoxicity | 7 (11) | 1 (2) | 1 (2) | — |
| Urinary tract infection | — | 1 (2) | — | — |
| Constipation | 1 (2) | — | — | — |
| Cardiotoxicity† | 1 (2)* | — | — | — |
| NGR-hTNF infusion reaction‡ | 1 (2) | — | — | — |